🇨🇴 Country Profile

Colombia

Fast-growing pharmaceutical trade with Colombia

🇨🇴 $199M
All data from DGCIS India export records (fiscal year, April–March).
$199M
Scale
Colombia's healthcare system receives $199M in Indian pharmaceutical products each year, affordable, quality medicine.
71%
Medicine
Primarily medicines (71%), supplemented by medicine ingredients and vaccines.
3.3×
Trajectory
One of the faster-growing relationships, India's pharmaceutical supply to Colombia has expanded 3.3× over the decade.
Context
Part of India's pharmaceutical supply network across Americas.
Impact
Indian pharmaceutical companies have both exported to and invested directly in Colombia, building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix, FY 2025–26 DGCIS
Medicines $142M (71.4%) Medicine Ingredients $36.7M (18.5%) Vaccines $10.9M (5.5%) Surgical & Hospital Supplies $7.8M (3.9%) Traditional & Herbal $1.3M (0.7%)
Top Products, FY 2025–26 DGCIS
Indian Pharma Investment in Colombia Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Colombia: $11.7M across 40 filings (2014-2025).